Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining Subgroups of Mitochondrial Disease and Dysfunction in Autism Spectrum Disorder

NCT02000284 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT02000284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02000284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining Subgroups of Mitochondrial Disease and Dysfunction in Autism Spectrum Disorder
Lead sponsor
University of Arkansas
Phase
Observational
Overall status
Active, not recruiting
Start date
October 16, 2012
Completion date
December 31, 2027
Enrollment
297 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorder, developmental delay, mitochondrial disease